Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2015-07-27FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplement for Diovan HCT (valsartan with hydrochlorothiazide) submitted by Novartis, updating the product labeling.
-
FDA label_change · 2015-07-27FDA Approved: DIOVAN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for DIOVAN (valsartan) submitted by Novartis Pharmaceuticals Corporation, resulting in changes to th…
-
FDA approval · 2015-07-27FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for the Bisoprolol Fumarate and Hydrochlorothiazide combination from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension
This entry notes the completion of a clinical trial evaluating Twynsta (telmisartan/amlodipine) with lifestyle modifications in Korean patie…
-
CLINICAL_TRIALS trial_result · 2015-07-27Clinical Trial Update: FFA Hypertension and Inflammation in Lean and Obese Subjects [NA]
Emory University completed a clinical trial examining the role of free fatty acids in hypertension and inflammation in lean and obese subjec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers [Phase 1]
Phase 1 study evaluating the pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects [Phase 1]
Phase 1 study evaluating pharmacokinetic interaction and safety after multiple oral doses of fimasartan/amlodipine and rosuvastatin in healt…
-
FDA approval · 2015-07-22FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental NDA for Lotensin (benazepril hydrochloride) filed by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject [Phase 1]
Phase 1 study assessing the safety and pharmacokinetics of Besylsartan tablets in healthy male volunteers.
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Nurse-led Reminder Program for the Prevention of Cardiovascular Diseases [NA]
A clinical trial update indicates that the nurse-led reminder program for the prevention of cardiovascular diseases has completed.
-
FDA approval · 2015-07-21FDA Approved: TRANDOLAPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Trandolapril (generic) under the ANDA program. This confirms regulatory cle…
-
FDA approval · 2015-07-15FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approved a supplemental application for TENORMIN (atenolol) submitted by Almatica Pharma LLC, updating the drug’s labeling as part of a …
-
FDA approval · 2015-07-15FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide from NorthStar Rx LLC.
-
FDA approval · 2015-07-15FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's supplemental application for a generic Losartan Potassium and Hydrochlorothiazide tablet prod…
-
FDA approval · 2015-07-15FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic valsartan and hydrochlorothiazide combination product manufactured by Mylan Pharma…
-
FDA approval · 2015-07-13FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application for clonidine hydrochloride submitted by Solco Healthcare LLC.
-
FDA approval · 2015-07-09FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approves a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) from Cosette Pharmaceuticals.
-
FDA approval · 2015-07-09FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
The FDA approved a supplemental NDA for Tenormin (atenolol) submitted by Almatica Pharma LLC, authorizing a supplemental labeling/indication…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: CKD-828 (80/5mg) Pharmacokinetic Study [Phase 1]
Phase 1 pharmacokinetic study of CKD-828 at 80/5 mg has been completed in hypertension.
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant [Phase 1]
Phase 1 safety study of lisinopril in children and adolescents with a kidney transplant has completed. Results were posted in 2015.
-
FDA approval · 2015-07-07FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium tablets from Aurobindo Pharma Limited (ANDA 090083). This is an approval of a…
-
FDA approval · 2015-07-07FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA approves a supplemental application for the combination drug benazepril hydrochloride and hydrochlorothiazide from Padagis US LLC.
-
CLINICAL_TRIALS research · 2015-07-07Clinical Trial Update: Epidemiological Study on the Relationship Between Respiratory Health and Air Pollution From Industrial Sources
This document provides an update on a completed epidemiological study by University Hospital Lille examining the relationship between respir…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Comparison of Single and Combination Diuretics in Low-Renin Hypertension [Phase 4]
This clinical trial update describes a Phase 4 study comparing single diuretics versus combination diuretics in low-renin hypertension. The …
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Optimum Treatment for Drug-Resistant Hypertension [Phase 4]
Phase 4 clinical trial update exploring optimal treatment for drug-resistant hypertension; current status is unknown.